Biochemistry & Molecular Biology Journal Open Access

Epigenetics Technology Market covers the market by research and diagnostics areas in Gene Regulation studies, biomarker detection and drug discovery. It includes the factors driving and controlling the market and also covers the market scheme in the United State, Europe, Asia and all the other countries. Its market is determined to achieve USD 1,605.7 Million up to 2022. It is USD 854.0 Million in 2017, with CAGR of 13.5% amid anticipated period. The development of the market is dealt with by the diminishing sequencing costs, increment in explore exercises, rising Pervasiveness of Malignancy, and great government financing for epigenetics. Epigenetics has been picking up significance as a promising logical approach for understanding the impact of the epigenetic instruments in malignancy and different sicknesses. Fast progressions have been happening particularly in the field of Therapeutics.

Industry is seeing a more extensive acknowledgment as more number of academic research colleges; biotech and Pharma organizations will embrace Epigenetics based approach in Diagnostics and therapeutics.

On the basis of application, the market is bifurcated into Oncology and non-oncology. Oncology is further sub-segmented into solid tumors & liquid tumors and non-oncology is further categorized into inflammatory diseases, Metabolic Diseases, infectious diseases, cardiovascular diseases, developmental biology, drug discovery, and other applications. On the basis of end user, the market is classified into academic & research institutes, pharmaceutical companies, biotechnology companies & contract research organizations (CROs). Geographically, the market is analysed across Europe, North America, Asia-Pacific, and LAMEA

Global Epigenetics Market was valued at $555 million in 2016, and is estimated to reach at $1,321 million by 2023, registering a CAGR of 13.1% from 2017 to 2023.

In view of geology, the business sector of Epigenetics is divided into North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into U.S. also, Canada.

The real players in the worldwide epigenetics business sector are Illumina, Inc. (U.S.), Abcam plc. (U.K), QIAGEN N.V. (Netherland), Merck and Co. (U.S.), New England Biolabs, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Active Motif (U.S.), Diagenode, Inc. (Belgium) and Zymo Research Corporation (U.S.)

Global Epigenetics Market, by Product

• Enzymes

• Instruments and Consumables

• Kits

• Reagents

• Bioinformatics Tools

Global Epigenetics Market, by Application

• Oncology

• Metabolic Diseases

• Developmental Biology

• Immunology

• Cardiovascular Diseases

• Other Applications

Global Epigenetics Market, by Technology

• DNA Methylation

• Histone Modifications

• Other Technologies

Global Epigenetics Market, By End User

• Academic and Research Institutes

• Pharmaceutical and Biotechnology Companies

• Contract Research Organizations (CROs)

Global Epigenetics Market, by Region

• North America

o US

o Canada

• Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

• Asia Pacific

o Japan

o China

o India

o Rest of Asia Pacific

• Latin America

• Middle East and Africa

Scope and Importance:

In biology, epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA Sequence. Epigenetics most often involves changes that affect gene activity and expression, but the term can also be used to describe any heritable phenotypic change. Such effects on cellular and physiological phenotypic traits may result from external or environmental factors, or be part of normal development. The standard definition of epigenetics requires these alterations to be heritable in the progeny of either Cells or organisms.

The term also refers to the changes themselves: functionally relevant changes to the genome that do not involve a change in the nucleotide sequence. Examples of mechanisms that produce such changes are DNA Methylation and histone modification, each of which alters how genes are expressed without altering the underlying DNA sequence. Gene Expression can be controlled through the action of repressor proteins that attach to silencer regions of the DNA. These epigenetic changes may last through cell divisions for the duration of the cell's life, and may also last for multiple generations, even though they do not involve changes in the underlying DNA sequence of the organism; instead, non-genetic factors cause the organism's genes to behave (or "express themselves") differently.

One example of an epigenetic change in eukaryotic biology is the process of cellular differentiation. During morphogenesis, totipotent Stem cells become the various pluripotent cell lines of the embryo, which in turn become fully differentiated cells. In other words, as a single fertilized egg cell – the zygote – continues to divide, the resulting daughter cells change into all the different cell types in an organism, including neurons, muscle cells, epithelium, endothelium of blood vessels, etc., by activating some genes while inhibiting the expression of others.

Historically, some phenomena not necessarily heritable have also been described as epigenetic. For example, the term "epigenetic" has been used to describe any modification of chromosomal regions, especially histone modifications, whether or not these changes are heritable or associated with a phenotype. The consensus definition now requires a trait to be heritable for it to be considered epigenetic.

Target Audience:

The organization working in:

• Genetics

• Genomics and Proteomics

• Bioinformatics

• Molecular Biology

• Medicine

• Organic Chemistry

• Natural Science field

• Stem cell biology

• Cancer

• Oncology

• Deans & Directors of Biology Universities and Institutes

• Scientists

• Biomedical companies

• Pharmaceutical companies

• Business Entrepreneurs

• Public wellbeing experts

Societies:

• Cigna International

• Medicus Mundi Switzerland

• FMH Swiss Medical Association

• Zanskar Health Association

• Swiss Society of Public Health

• The Alliance for Surgery and Anesthesia Presence (ASAP)

• AO Foundation

• Banff Foundation for Allograft Pathology

• Drugs for Neglected Diseases Initiative

• European Federation of Sports Medicine Associations

• European League Against Rheumatism

• Federal Office of Public Health

Associations / Hospitals:

• Fédération Internationale de Medicine Sportive

• Global Forum for Health Research

• Health On the Net Foundation

• International Board for Medical Research and Studies

• International Centre for Migration and Health

• International Osteoporosis Foundation

• Medicines for Malaria Venture

• Medicus Mundi International

• ON Foundation

• Pharmazie-Historisches Museum der Universität Basel

• Red Cross service

• Swiss Medical Students’ Association

• Swiss Personalised Health Network

• Swiss Red Cross

• Swissmedic

• Toothfriendly International

• Zwischengeschlecht

• Am Rosenberg Clinic, Heiden

• Andreas Clinic, Cham

• Beau-Site Clinic, Bern

• Belair Clinic, Schaffhausen

• Bethesda-Spital, Basel

• Birshof Clinic, Basel

• Centre hospitalier Bienne [fr; de], Biel-Bienne

• Bruderholzspital, Basel

• Bürgerspital, Solothurn

• Geneva University Hospitals, Geneva

• University Hospital of Lausanne (CHUV), Lausanne

• Hirslanden Clinique Cecil, Lausanne

• Hirslanden Clinique Bois-Cerf, Lausanne

• Hirslanden Clinique La Colline, Geneva

• Clinique de Montchoisi, Lausanne

• Clinique Générale St-Anne Fribourg

• Clinique Laclaire Montreux

• Clinique La Source Lausanne

• Claraspital, Basel

• Ente Ospedaliero Cantonale, Ticino

• Felix Platter-Spital, Basel

• Hirslanden Clinic, Zurich

• Hirslanden Clinic, Aarau

• Im Park Clinic, Zurich

• Kantonsspital, Aarau

• Kantonsspital, Olten

• Kantonsspital, Baden

• Kantonsspital, Liestal

• Kantonsspital, Lucerne

• Kantonsspital St. Gallen

• Kantonsspital, Männedorf

• Lindenhofspital, Bern

• Merian Iselin-Spital, Basel

• Ospedale Civico, Lugano

• Ospedale Italiano, Lugano

• Ospedale San Giovanni, Bellinzona

• Permanence Clinic, Bern

• Regionalspital, Burgdorf

• Regionalspital, Langenthal

• Regionalspital, Langnau im Emmental

• Regionalspital, Thun

• Salem Hospital, Bern

• See Spital, Zurich

• St. Anna Clinic, Lucerne

• Stadtspital Triemli, Zurich

• Swiss Paraplegic Centre, Nottwil

• Sonnenhof Hospitals Ltd., Klinik Sonnenhof & Klinik Engeried Bern

• Spital Thusis, Graubünden

• Tiefenauspital, Bern

• University Hospital of Basel

• University Hospital of Bern

• University Hospital of Zurich

• Waidspital, Zurich

• Zieglerspital, Bern

• Klinik Gut St.Moritz

• Regionalspital Samedan

Sara Berkeley | Program Coordinator |
Biochemistry & Molecular Biology Conference
Email: epigenetics@europeannualconference.org;
Phone: +1-213-233-9462; WhatsApp Number: +44-203-7690-972

• 7^th World Congress on Epigenetics and Chromosome

  June 24-25, 2020

  Zurich, Switzerland